- KR Bharat
- 2025-12-15
Around 200 children across several European countries were conceived using sperm from a single donor who unknowingly carried a rare genetic mutation linked to early-onset cancers, raising serious concerns about gaps in genetic screening and international fertility regulations.
The case, which has come to light recently, has had devastating consequences. Several children have already died, while many affected families are now living with the fear of inherited cancer risk. The incident has triggered urgent questions about how one donor’s sperm was used so extensively across borders and why existing safeguards failed to detect a mutation with such severe implications.
Experts point out that while sperm and egg donors are screened for a range of common inherited conditions, the process varies from country to country and has clear limitations. Screening often relies on accurate family medical histories, which are not always complete or known, allowing rare but dangerous mutations to go undetected.
The tragedy has highlighted the urgent need for stronger international oversight, better genetic testing protocols, and coordinated cross-border tracking of donors to prevent similar incidents in the future.
